ANIP FY 2009 Earnings — ANI Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

ANIPANI Pharmaceuticals, Inc.

$2B

FY 2009 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1M-66.7% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$38M-3054.4% margin

Net Income

-$48M-3777.9% margin

EPS (Diluted)

$-50.39

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$19M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$36M

Total Liabilities

$21M

Stockholders' Equity

$16M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$4M	-66.7%
Gross Profit	$1M	$4M	-66.7%
Operating Income	-$38M	-$18M	-113.3%
Net Income	-$48M	-$17M	-172.8%